Latest Europe News

Page 34 of 133
Medical Developments International has posted positive operating cashflow for the first half of FY26, driven by robust growth in its flagship product Penthrox across Australia and Europe, alongside progress in paediatric approvals.
Ada Torres
Ada Torres
30 Jan 2026
Little Green Pharma reports record quarterly revenue and announces a transformative merger with Cannatrek, creating a leading vertically integrated medicinal cannabis group with strong European growth prospects.
Ada Torres
Ada Torres
30 Jan 2026
Aurora Labs has marked a significant milestone by securing its first purchase order for micro gas turbine engines, alongside strategic MOUs with major defence groups and a $5.5 million capital raise to fuel growth.
Victor Sage
Victor Sage
30 Jan 2026
Argosy Minerals has made significant strides in developing its Rincon Lithium Project in Argentina, securing a crucial 40MW power connection and executing a lithium carbonate spot sales contract, all while navigating a buoyant lithium market.
Maxwell Dee
Maxwell Dee
30 Jan 2026
European Metals Holdings has marked a pivotal quarter with the completion of a Definitive Feasibility Study for its Cinovec Lithium Project, securing a €360 million Czech government grant and submitting a key Environmental Impact Assessment, propelling the project closer to production.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.
Ada Torres
Ada Torres
29 Jan 2026
ASF Group Limited closed December 2025 with $1.91 million in cash and nearly four quarters of funding runway, while progressing key investments in mining, technology, and biotech sectors.
Victor Sage
Victor Sage
29 Jan 2026
Immutep Limited has entered a strategic collaboration with Dr. Reddy’s, receiving a A$30 million upfront payment and potential milestones up to A$528 million, while reporting promising clinical progress across multiple cancer immunotherapy trials.
Ada Torres
Ada Torres
29 Jan 2026
Bioxyne Limited has delivered a record-breaking second quarter in FY2026, posting $17.2 million in revenue and expanding its footprint into key international markets. The company’s growth is underpinned by new contracts, innovative psychedelics products, and strategic government funding.
Victor Sage
Victor Sage
29 Jan 2026
Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.
Ada Torres
Ada Torres
29 Jan 2026
Stakk Ltd aims to nearly double its annual recurring revenue to $15 million by mid-2026, driven by a strong enterprise pipeline and a flagship deployment of its new Mobile IQ SDK with Robinhood. This move underscores Stakk’s growing footprint in embedded finance security.
Sophie Babbage
Sophie Babbage
29 Jan 2026
SRJ Technologies has completed the first phase of its growth strategy and is now advancing into market penetration with a significant $23.8 million joint venture in the Middle East and a key board appointment.
Maxwell Dee
Maxwell Dee
29 Jan 2026